ACRO BIOMEDICAL CO., LTD. (ACBM) Revenue 2017–2025
ACRO BIOMEDICAL CO., LTD. (ACBM) annual revenue history from SEC filings — each fiscal year as reported, with year-over-year change.
$0FY2025 · since FY2017: $510,000 → $0
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $0 | — |
| FY2024 | $0 | — |
| FY2023 | $0 | -100.0% |
| FY2022 | $658,500 | -45.0% |
| FY2021 | $1.2M | +74.1% |
| FY2020 | $687,964 | +255.5% |
| FY2019 | $193,536 | -97.6% |
| FY2018 | $8.0M | +1471.5% |
| FY2017 | $510,000 | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More ACBM financial trends
ACBM Net incomeACBM Net marginACBM Gross profitACBM Gross marginACBM Operating incomeACBM Operating marginACBM Operating cash flowACBM Free cash flowACBM Capital expendituresACBM Return on equityACBM Stock buybacksACBM Dividends paidACBM Total assetsACBM Total liabilitiesACBM Shareholders’ equityACBM overview →